S. Antonenko and G. Telegeev, “Inhibition of USP1, a new partner of Bcr-Abl, results in decrease of Bcr-Abl level in K562 cells”, Exp. oncol., vol. 42, no. 2, pp. 109–114, Jun. 2023.